Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature
APPLE trial investigators and Childhood Rheumatology Research Alliance (CARRA)
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature'. Together they form a unique fingerprint.